Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.36 |
| ▸ | PPARG | P37231 | 2/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.33 |
| ▸ | RELA | Q04206 | 2/20 | 0.33 |
| ▸ | PRKCA | P17252 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6324831 | 0.95 | NFKB1 (0.34) | TYRNFKB1NFKB2RELAPRKCA | |
| SCHEMBL6331105 | 0.88 | PPARG (0.30) | PPARG | |
| SCHEMBL6327705 | 0.88 | TYR (0.42) | TYRPPARGNFKB1NFKB2RELA | |
| SCHEMBL6327710 | 0.88 | TYR (0.42) | TYRPPARGNFKB1NFKB2RELA | |
| SCHEMBL6331408 | 0.87 | TYR (0.36) | TYRPPARGNFKB1NFKB2RELA | |
| SCHEMBL6331667 | 0.86 | TYR (0.41) | TYRPPARGNFKB1NFKB2RELA | |
| SCHEMBL6331669 | 0.86 | TYR (0.41) | TYRPPARGNFKB1NFKB2RELA | |
| SCHEMBL6332136 | 0.84 | TYR (0.44) | TYRPPARGNFKB1NFKB2RELA | |
| SCHEMBL6331186 | 0.84 | TYR (0.41) | TYRPPARGNFKB1NFKB2RELA | |
| SCHEMBL6332133 | 0.84 | TYR (0.44) | TYRPPARGNFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | ZEON CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-1420005-A1 | CYCLOPENTANONE DERIVATIVE | Zeon Corporation (JP) | 2004-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | PTGIS, CYP51A1, TRPA1 | TYR 1890/4885PPARG 1670/4885NFKB1 853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.